Abstract: Aspects of the disclosure relate to using synthetic DNA stranding and mutant nucleotide processes to conduct enterprise market volatility predictions. In some embodiments, a computing platform may receive raw market data from a plurality of lines of business of an enterprise organization. Thereafter, the computing platform may preprocess the raw market data to obtain enterprise level market data, execute synthetic DNA stranding of the enterprise level market data to obtain synthetic DNA stranded market data, run the synthetic DNA stranded market data through one or more market volatility models, and compile results from the market volatility models on the synthetic DNA stranded market data. The computing platform may transmit results from the market volatility models on the synthetic DNA stranded market data. The transmitted results may be configured to display a market application interface that includes market volatility forecasting parameters based on results of the market volatility models.

Abstract: Aspects of the disclosure relate to using synthetic DNA stranding and mutant nucleotide processes to conduct enterprise market volatility predictions. In some embodiments, a computing platform may receive market data from a plurality of lines of business across an enterprise, wherein the market data is received in a raw, uncompressed format. Thereafter, the computing platform may assimilate and preprocess the market data to output vectored market data. The computing platform may perform a synthetic DNA stranding process on the vectored market data to create one or more strands of synthetic DNA market data, and output the one or more strands of synthetic DNA market data to a synthetic DNA client server, wherein the one or more stands of synthetic DNA market data is configured for input in a market volatility prediction model.

Abstract: Aspects of the disclosure relate to using synthetic DNA stranding and mutant nucleotide processes to conduct enterprise market volatility predictions. In some embodiments, a computing platform may initiate a set of instructions associated with performing an action on a synthetic DNA market data set associated with a plurality of lines of business across an enterprise organization. Thereafter, the computing platform may convert the set of instructions to a mutant nucleotide sequence, and insert the mutant nucleotide sequence into the synthetic DNA market data set. The computing platform may extract, using the mutant nucleotide sequence, target information from the synthetic DNA market data set, and validate the target information to detect one or more anomalies. The computing platform may remove the one or more data anomalies, and subsequently output a validated synthetic DNA market data set to a synthetic DNA client server.

Abstract: The output of an autoencoder model is used to provide reasons for classifying logged event data as anomalous. Multivariate input feature vectors based on the event data are applied to the autoencoder model to generate corresponding predicted multivariate feature vectors with respective feature elements. Each feature element of each vector corresponds to a respective type of event data (e.g., sign-in failures). A reconstruction loss is determined for each predicted feature vector and used to classify the predicted feature vector as anomalous or not anomalous. Reason(s) for an anomaly classification are determined by selecting one or more feature elements based on a level of percent contribution to the vectors loss and underprediction or overprediction, determined for each feature element of the anomalous predicted feature vector. Each reason is related to the type of event associated with a selected feature element. The reasons may be displayed in a security analytics UI.

Abstract: Devices and methods for treatment of a patient's vasculature are described. Embodiments may include an implant having multiple mesh layers. A first and second layer of the implant may be formed by folding over a single mesh and the third layer may be formed from a different mesh. The first, second, and third layers may be either a stasis or a structural layer and may be arranged in different orders. Embodiments may also include structures to assist in the expansion of the device. These structures may include an expandable loop or reinforcing finger extensions. Embodiments may also include a corrugation or ridge around a middle section of the implant to assist in deployment.

Abstract: Devices and methods for treatment of a patient's vasculature are described. Embodiments may include a permeable implant having a radially constrained state configured for delivery within a catheter lumen, an expanded state, and a plurality of elongate filaments that are woven together. The permeable implant may include a support structure having a plurality of scaffolding filaments where each of the plurality of scaffolding filaments has a diameter that is larger than a diameter of each of the plurality of elongate filaments of the first permeable shell.

Abstract: Various embodiments of a variable geometry quadrotor with a compliant frame are disclosed, which adapts to tight spaces and obstacles by way of passive rotation of its arms.

Abstract: Devices and methods for treatment of a patient's vasculature are described. Embodiments may include an implant having an expandable frame made up of a plurality of elongate biodegradable filaments that extend from a proximal to distal end of the implant, and a permeable shell that extends from the proximal end to a middle region of the expandable frame. Embodiments may also include an implant having a first permeable shell having a proximal hub and an open distal end and a second permeable shell having a distal hub and an open proximal end. The distal end of the first permeable shell may be releasably coupled to the proximal end of the second permeable shell.

Abstract: Various embodiments of a system and associated method for a thrust-vector controlled unmanned aerial and ground vehicle are disclosed herein.

Abstract: Systems herein allow a user device to monitor calendar events with a secure bubble application. When an event is upcoming, the secure bubble application can present a notification. The secure bubble application can search other managed applications for content relevant to the meeting event. The secure bubble application can extract text, tags, and other metadata from the calendar event and any attached files. The text, tags, and other metadata can be used to search each managed application. Relevant emails, files, and notes can be displayed in a card generated by the secure bubble application.

Abstract: Small molecule carbazole compounds for use as androgen receptor inhibitors are provided herein. Also provided herein are methods for using the carbazole compounds in treating prostate cancer, including castration-resistant prostate cancer and enzalutamide-resistant prostate cancer. The methods include administering to a subject an effective amount of a compound or composition as described herein.

Abstract: Systems herein allow a user device to monitor calendar events with a secure bubble application. When an event is upcoming, the secure bubble application can present a notification. The secure bubble application can search other managed applications for content relevant to the meeting event. The secure bubble application can extract text, tags, and other metadata from the calendar event and any attached files. The text, tags, and other metadata can be used to search each managed application. Relevant emails, files, and notes can be displayed in a card generated by the secure bubble application.

Abstract: Embodiments of the present disclosure provide systems and methods for recognizing a masked face. According to the present disclosure, the disclosed systems and methods include features that provide augmentation of existing face recognition databases, real-time mask detection, and real-time masked face recognition. In embodiments, masked face recognition includes a multi-layered approach, which includes finding matching simulated masked faces in the database that match the masked face being analyzed, comparing the unmasked portion of the masked face to stored unmasked faces in a database to identify any matches, and executing face restoration algorithms in which the masked portion is reconstructed to generate an unmasked representation which may then be matched against unmasked faces in the database.

Abstract: Unstructured data items are stored at an object storage service. A filtering requirement to be used to generate a result set for an access request is determined. Using a transformed representation of the filtering requirement, a target set of tokens of the filtering requirement which are to be obfuscated within a log record is identified. A log record that comprises substitute tokens for the target set of tokens is generated and stored.

Abstract: Devices and methods for treatment of a patient's vasculature are described. Embodiments may include a permeable implant having a radially constrained state configured for delivery within a catheter lumen, an expanded state, and a plurality of elongate filaments that are woven together. The permeable implant may include a stiffer proximal portion that is configured to sit at the neck of an aneurysm. The stiffer proximal portion may include additional mesh layers or a structural support with scaffolding wires.

Abstract: Unstructured data items are stored at an object storage service. A filtering requirement to be used to generate a result set for an access request is determined. Using a transformed representation of the filtering requirement, a target set of tokens of the filtering requirement which are to be obfuscated within a log record is identified. A log record that comprises substitute tokens for the target set of tokens is generated and stored.

Abstract: Small molecule carbazole compounds for use as androgen receptor inhibitors are provided herein. Also provided herein are methods for using the carbazole compounds in treating prostate cancer, including castration-resistant prostate cancer and enzalutamide-resistant prostate cancer. The methods include administering to a subject an effective amount of a compound or composition as described herein.

Abstract: An image display method is provided. The image display method includes displaying a camera preview screen that provides an image of a subject in real time, capturing one or more images by capturing the camera preview screen, and displaying a photo reel on the camera preview screen, the photo reel being generated by arranging thumbnails of the captured one or more images in a row.

Abstract: A method and apparatus model multiple relationship dimensions among a set of entities is presented. A computer system identifies a configuration for the structure. The configuration comprises metadata about supported relationship aspects for the set of entities within a structure context. The computer system identifies aspects for an entity according to the structure context. The entity aspects comprise metadata about relationships for the entity within the structure context. The computer system compares the entity aspects to the configuration for the structure to determine a relationship of the entity to the set of entities. The computer system dynamically attaches the entity to the set of entities according to the determined relationship to form the structure.

Abstract: Unstructured data items are stored at an object storage service. A filtering criterion to be used to generate a result set for an access request is determined. A test that can be used to determine, without completing parsing of a record identified in an unstructured data item, whether the record satisfies the filtering criterion is identified. Parsing of a particular record is abandoned in response to determining, using the test, that the record satisfies the filtering criterion. A response to the access request is determined using a subset of records that satisfy the filtering criterion.